News

Merck, a leading company for innovative and top-quality high-tech products in the healthcare, life science and performance materials sectors, announced today that it has entered into a license agreement with Tridonic Jennersdorf GmbH (Tridonic) covering silicate phosphors for use...

Active cancer/peptide cancer immunotherapy remains an exciting and rapidly advancing field in oncology. Peptide cancer vaccines are an attractive therapeutic option as they are safe and easily produced and administered(for breast cancer) . ...

Ian Read, chairman and chief executive officer, Pfizer Said, We are pleased that Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, is now part of Pfizer. We want to welcome...

New clinical data demonstrating the range of treatment options represented in Lilly's diabetes portfolio will be presented in 79 abstracts on June 5-9, at the 75th American Diabetes Association (ADA)® Scientific Sessions in Boston. These presentations...

- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, acquired the Scottish company BioOutsource Ltd. The privately owned company based in Glasgow, UK, has been operating in the biotechnology market since 2007, and in the...

Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, by using its patented CriPec® platform announced today the appointment of Jeroen Tonnaer as new Chief Business Officer responsible for Cristal Therapeutics’ business development,...

Aduro Biotech has received orphan drug designation from US Food and Drug Administration (FDA) for its immuno-oncology product candidate CRS-207 to treat mesothelioma. Mesothelioma is a form of cancer that affects the smooth layer of mesothelial...